Dr. Sibel Aydin is a Professor of Medicine at the University of Ottawa, Associate Scientist at the Ottawa Hospital Research Institute (OHRI), Director of Research at the Arthritis Centre in Ottawa, and holds a Tier 2 Research Chair in Inflammatory Arthritis.

She serves on the GRAPPA Steering Committee and is Vice President of the Canadian Rheumatology Ultrasound Society (CRUS). She is a member of several national and international initiatives, including task forces addressing difficult-to-treat disease in psoriatic arthritis and axial spondyloarthritis, and has contributed to the development of Canadian treatment recommendations for psoriatic arthritis.

Her research focuses on inflammatory arthritis, particularly psoriatic arthritis and spondyloarthritis, with an emphasis on imaging, disease phenotyping, and personalized treatment strategies. She has authored more than 180 peer-reviewed publications.

I do not have an affiliation (financial or otherwise) with any for-profit or not-for-profit organizations.

I intend to make therapeutic recommendations for medications that have not received regulatory approval (ie, “off-label” use of medications).